Hidenobu Kuniyoshi

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Fujifilm Corporation. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidenobu Kuniyoshi. Retrieved from https://idiyas.com/inventor/hidenobu-kuniyoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 62.5

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Kanagawa, JP (2011 - 2018)
Ashigarakami-gun, JP (2014 - 2019)

Company Filing History:

8 out of 16,949

Fujifilm Corporation

patents

Years Active: 2011-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709629 - CYCLOPENTENYL PURINE DERIVATIVE OR SALT THEREOF (2026-08-18),

2. 12202850 - Cyclobutyl purine derivative or salt thereof (2025-01-21),

3. 10385089 - Thionucleoside derivative or salt thereof, and pharmaceutical composition (2019-08-20),

4. 10059734 - Thionucleoside derivative or salt thereof, and pharmaceutical composition (2018-08-28),

5. 9884882 - Method for producing thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate (2018-02-06),

6. 9051310 - Nicotinamide derivative or salt thereof (2015-06-09),

7. 8895585 - Nicotinamide derivative or salt thereof (2014-11-25),

8. 7871596 - Higher fatty acid triester compound having diethylenetriamine-type metal chelate structure (2011-01-18),

Title: Hidenobu Kuniyoshi: Innovator in Pharmaceutical Chemistry

Introduction

Hidenobu Kuniyoshi is a prominent inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on developing compounds that exhibit remarkable efficacy in treating various medical conditions.

Latest Patents

Among his latest patents is a cyclobutyl purine derivative or salt thereof. This invention aims to provide a compound that demonstrates excellent drug efficacy as an anti-adenoviral agent. Another notable patent is for a thionucleoside derivative or salt thereof, along with a pharmaceutical composition. This invention targets tumors, particularly those that have developed resistance to gemcitabine, showcasing his commitment to advancing cancer treatment.

Career Highlights

Hidenobu Kuniyoshi is currently associated with Fujifilm Corporation, where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also had a significant impact on the medical community.

Collaborations

He has collaborated with notable colleagues, including Hideyasu Fujiwara and Shinsuke Mizumoto, further enhancing the scope and impact of his research.

Conclusion

Hidenobu Kuniyoshi's contributions to pharmaceutical chemistry through his innovative patents reflect his dedication to improving healthcare solutions. His work continues to inspire advancements in drug development and treatment efficacy.

Profile summary based on public USPTO records.